Tectonic Therapeutic posts favorable Phase 1a safety and PK results for TX2100, plans Phase 1b/2

Tectonic Therapeutic announced favorable Phase 1a safety, tolerability and PK results for TX2100 and FDA Fast Track plus IND clearance.Key Highlights:Original SEC Filing: Tectonic Therapeutic, Inc. [ TECX ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may contain inaccuracies. Consider ve…